For UK MedTech companies
Post-market surveillance obligations are consuming resource that should be going on commercial development
UKCA and MDR post-market surveillance requirements are significant and growing. For most MedTech companies, PMS is being managed manually, creating compliance risk, quality system burden, and commercial team distraction.
Cost of Inaction
Enter the number of devices needing PMS data, the hours a year each takes, and your hourly PMS staff cost. The calculator shows the annual cost of manual post-market surveillance.
How it breaks down
- Manual PMS data collection£120,000
Two minutes, no typing, and I read every one myself.
From Paul
Tell me where that £120,000 is coming from, and I'll come back with the three things to fix first.
A few quick questions, about two minutes, and no typing. I read every one myself and reply with the three things costing you most and where I'd start. If it's useful, we talk. If not, you've still got a clear picture.
No obligation, no sales call unless you ask for one, and nothing automated lands in your inbox.
Paul, Solvable
Frequently asked questions
Why does this problem persist?
Post-market surveillance data is gathered manually and repeatedly Obligations grow but the process to meet them does not scale The work falls on commercial or clinical staff by default
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.